Literature DB >> 22923749

Measuring fatigue in SSc: a comparison of the Short Form-36 Vitality subscale and Functional Assessment of Chronic Illness Therapy-Fatigue scale.

Daphna Harel1, Brett D Thombs, Marie Hudson, Murray Baron, Russell Steele.   

Abstract

OBJECTIVE: Fatigue is a common and important problem in SSc. No studies, however, have compared the properties of fatigue measures in SSc. The objective of this study was to compare the performances of the Short Form-36 (SF-36) Vitality subscale and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT) in SSc.
METHODS: Cross-sectional, multi-centre study of Canadian Scleroderma Research Group Registry patients. The associations of the two instruments with other patient-reported outcome measures, as well as physician- and patient-rated disease variables were compared. Item response theory models were used to compare the degree to which items and the total scores of each measure effectively covered the full spectrum of fatigue levels.
RESULTS: There were 348 patients (297 women, 85%) in the study. The instruments correlated at r = 0.65 with each other. The FACIT tended to correlate slightly higher than the SF-36 Vitality subscale with physician- and patient-rated disease variables and patient-reported physical function and disability, whereas the SF-36 Vitality subscale correlated minimally higher with mental health measures. The FACIT had markedly better discrimination across the range of fatigue, particularly at average to high fatigue levels, whereas the SF-36 Vitality subscale discriminated well only among patients in the low to average range.
CONCLUSION: The FACIT discriminates better than the SF-36 Vitality subscale at average to high ranges of fatigue, which is common in SSc, suggesting that it is preferred for measuring fatigue in SSc.

Entities:  

Mesh:

Year:  2012        PMID: 22923749     DOI: 10.1093/rheumatology/kes206

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  8 in total

Review 1.  Fatigue in rheumatic diseases.

Authors:  Sevinç Can Sandıkçı; Zeynep Özbalkan
Journal:  Eur J Rheumatol       Date:  2015-09-01

2.  Symptom cluster, healthcare use and mortality in patients with severe chronic obstructive pulmonary disease.

Authors:  Soo Kyung Park; Janet L Larson
Journal:  J Clin Nurs       Date:  2014-01-27       Impact factor: 3.036

3.  The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients.

Authors:  Brooke Levis; Linda Kwakkenbos; Marie Hudson; Murray Baron; Brett D Thombs
Journal:  Clin Rheumatol       Date:  2016-12-10       Impact factor: 2.980

4.  The comparability of English, French and Dutch scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): an assessment of differential item functioning in patients with systemic sclerosis.

Authors:  Linda Kwakkenbos; Linda M Willems; Murray Baron; Marie Hudson; David Cella; Cornelia H M van den Ende; Brett D Thombs
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

5.  Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).

Authors:  Ariane L Herrick; Xiaoyan Pan; Sébastien Peytrignet; Mark Lunt; Roger Hesselstrand; Luc Mouthon; Alan Silman; Edith Brown; László Czirják; Jörg H W Distler; Oliver Distler; Kim Fligelstone; William J Gregory; Rachel Ochiel; Madelon Vonk; Codrina Ancuţa; Voon H Ong; Dominique Farge; Marie Hudson; Marco Matucci-Cerinic; Alexandra Balbir-Gurman; Øyvind Midtvedt; Alison C Jordan; Paresh Jobanputra; Wendy Stevens; Pia Moinzadeh; Frances C Hall; Christian Agard; Marina E Anderson; Elisabeth Diot; Rajan Madhok; Mohammed Akil; Maya H Buch; Lorinda Chung; Nemanja Damjanov; Harsha Gunawardena; Peter Lanyon; Yasmeen Ahmad; Kuntal Chakravarty; Søren Jacobsen; Alexander J MacGregor; Neil McHugh; Ulf Müller-Ladner; Gabriela Riemekasten; Michael Becker; Janet Roddy; Patricia E Carreira; Anne Laure Fauchais; Eric Hachulla; Jennifer Hamilton; Murat İnanç; John S McLaren; Jacob M van Laar; Sanjay Pathare; Susannah Proudman; Anna Rudin; Joanne Sahhar; Brigitte Coppere; Christine Serratrice; Tom Sheeran; Douglas J Veale; Claire Grange; Georges-Selim Trad; Christopher P Denton
Journal:  Ann Rheum Dis       Date:  2017-02-10       Impact factor: 19.103

6.  Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis.

Authors:  André La Gerche; Mandana Nikpour; Laura Ross; Anniina Lindqvist; Benedict Costello; Dylan Hansen; Zoe Brown; Jessica A Day; Wendy Stevens; Andrew Burns; Warren Perera; Marcus Pianta
Journal:  Arthritis Res Ther       Date:  2022-04-11       Impact factor: 5.156

7.  The Turkish Version of Multidimensional Assessment of Fatigue and Fatigue Severity Scale is Reproducible and Correlated With Other Outcome Measures in Patients With Systemic Sclerosis.

Authors:  Kevser Gök; Gizem Cengiz; Kemal Erol; Salih Özgöçmen
Journal:  Arch Rheumatol       Date:  2016-05-17       Impact factor: 1.472

8.  Clinical trial protocol: PRednisolone in early diffuse cutaneous Systemic Sclerosis (PRedSS).

Authors:  Ariane L Herrick; Deborah J Griffiths-Jones; W David Ryder; Justin C Mason; Christopher P Denton
Journal:  J Scleroderma Relat Disord       Date:  2020-09-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.